Searched for
BLENREP
European shares end flat as markets assess earnings flurryEuropean shares remained stable on Friday, balancing healthcare losses with gains in oil and gas, concluding a week of corporate earnings. ...- GSK launches $2.5 bln buyback, lifts sales target after stellar Q4GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, bett...
- Stocks in news: Adani Ports, REC, Maruti Suzuki, Hero MotoCorp, MosChip TechEquity markets await BJP's election outcome on June 4. GSK's Blenrep shows promise for multiple myeloma. NMDC reports 37% production fall i...
- GSK blood cancer drug nearly halves risk of death in late-stage trialIn the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with th...
- GSK to boost spending power of pharma business post break-upGlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day. GSK's s...
Load More